FDA Issues Communication about Safety Review of Xolair
The FDA is evaluating interim safety findings from an ongoing study of Xolair (omalizumab) that suggests an increased number of cardiovascular and cerebrovascular adverse events in a group of patients using Xolair compared to a group of patients not given the drug (control group).
Xolair is approved for use by adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who test positive for reactivity to a perennial airborne allergen, and whose symptoms are inadequately controlled with inhaled corticosteroids.
The ongoing study, titled Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS), is an observational study of approximately 5000 Xolair treated patients and a control group of approximately 2500 non-Xolair treated patients. The primary objective of the EXCELS study is to assess the long-term safety profile of Xolair in patients followed for 5 years. Study patients are 12 years of age and older with moderate to severe persistent asthma and who have a positive skin test or blood test for an aeroallergen.
The interim data, submitted by the manufacturer of Xolair (Genentech), suggests a disproportionate increase in ischemic heart disease, arrhythmias, cardiomyopathy and cardiac failure, pulmonary hypertension, cerebrovascular disorders, and embolic, thrombotic and thrombophlebitic events in patients treated with Xolair compared to the control group of patients not given the drug.
JULY-17-09: Ongoing Safety Review of Omalizumab, marketed as Xolair [FDA: EARLY COMMUNICATION ABOUT AN ONGOING SAFETY REVIEW OF XOLAIR]
If you or a loved one has suffered an adverse event as a result of using this medication, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Related Law Suits
Xolair Law Suit and Settlement
FDA Law Suit and Settlement
CVS Law Suit and Settlement
Louisiana, USA Law Suit and Settlement
Miralus Inc. Law Suit and Settlement
Vytorin Law Suit and Settlement
Pesticides Law Suit and Settlement
Medtronic Inc. Law Suit and Settlement
Xiadafil VIP Law Suit and Settlement
Oral HRT Law Suit and Settlement
See more stories from this source.
Class Action Law Suits
Newsworthy Law Suits
Defective Products Lawsuits
Drug & Medical Claims Lawsuits
Food & Dietary Supplement Lawsuits
Personal Injury Lawsuits
Real Estate Lawsuits
Investment Fraud Lawsuits
Related Law Articles
Related Law Questions
Related Law Bulletins
Lawyers! Become an Approved Expert to Answer Questions.
You'll get lots of targetted traffic to your website and new client leads!